Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2005
06/30/2005US20050142547 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
06/30/2005US20050142546 Assays for identifying modulators of rhomboid polypeptides
06/30/2005US20050142545 Methods for identifying small molecules that bind specific rna structural motifs
06/30/2005US20050142544 A genotype is considered as a DNA based link between the situations of the combination, then used in a further consideration, including the review of possible matches between that genotype and a collection of genotype records; genotypes are ranked within the combined set or evaluation
06/30/2005US20050142543 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
06/30/2005US20050142541 Antibodies for oncogenic strains of HPV and methods of their use
06/30/2005US20050142540 Methods and reagents for molecular detection of HIV-1 groups M, N and O
06/30/2005US20050142537 System and method for rapid detection of metabolic deviations of a biological sample
06/30/2005US20050142536 Method and kit for the detection of a novel coronoavirus associated with the severe acute respiratory syndrome (SARS)
06/30/2005US20050142535 Ogligonucleotides comprising alternating segments and uses thereof
06/30/2005US20050142534 Treat cells growth regions with endonuclease, nucleic acid stain; evaluate interactions between cells, and between cells and matrix materials, cellular distribution patterns indicate invasive potential of cells; indicate preferred sites of metastasis, efficacy of an anticancer drug
06/30/2005US20050142149 Virulence genes and proteins, and their use
06/30/2005US20050142146 Vaccine; against Chlamydia pneumonia; therapy, prevention of infections,
06/30/2005US20050142144 Epitope sequences
06/30/2005US20050142142 recombinant T cell receptor ligand (RTL) for use treating autoimmune diseases
06/30/2005US20050142138 Endothelial cell expression patterns
06/30/2005US20050142122 Brassica plant resistant to the fungus leptosphaeria maculans (blackleg)
06/30/2005US20050142119 Pluri-differentiated mesenchymal progenitor cell for use as tissue propagation tool in regenerative medicine; tissue engineering and repair
06/30/2005US20050142113 Pharmaceutical composition having a parasite with a chorismate synthase gene that is knocked out; for use against apicomplexan parasites which cause malaria, toxoplasmosis, sryptosporidiosis, and eimeriosis
06/30/2005US20050142067 Zintrodes, multitrodes and uses thereof
06/30/2005US20050142064 Administering test drug infected with adenovirus used as a vector and engineered by incorporating a detectable reporter gene and having human PXR binding regions falling within an untranslated region of a human CY3A gene; genetic engineering and expression; gene therapy; drug screening
06/30/2005US20050141592 Test element for analyzing sample material
06/30/2005US20050139489 Method of reducing the effect of direct and mediated interference current in an electrochemical test strip
06/30/2005US20050139469 Electrochemical test strip for reducing the effect of direct and mediated interference current
06/30/2005DE10356837A1 New conjugates useful for modifying nucleic acid chains comprise nucleotide or nucleoside molecules coupled to a label through water-soluble polymer linkers
06/30/2005DE10356751A1 Detecting prokaryotic mRNA, useful for gene expression profiling, includes reverse transcription after incorporation of RNA polymerase recognition site to form double-stranded cDNA for transcription
06/30/2005DE10356218A1 Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Pyruvatkinasen aus Pilzen A method for identifying fungicidally active compounds based on Pyruvatkinasen from fungi
06/30/2005DE10353419B3 Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA-Sequenzen mittels hemimethylierungssensitiver Restriktionsenzyme A method for the examination of cytosine methylations in DNA sequences using restriction enzymes hemimethylierungssensitiver
06/30/2005DE10345009A1 Verwendung von Flamingo Antagonisten und/oder Agonisten zur Diagnose und Behandlung von Krebs Use of Flamingo antagonists and / or agonists for the diagnosis and treatment of cancer
06/30/2005CA2771330A1 Methods and materials for canine breed identification
06/30/2005CA2733144A1 Methods and materials for canine breed identification
06/30/2005CA2568991A1 Method and apparatus for measuring environmental allergen
06/30/2005CA2560045A1 Methods and compositions comprising bacteriophage nanoparticles
06/30/2005CA2550893A1 Molecular signature of the pten tumor suppressor
06/30/2005CA2550219A1 Methods and materials for canine breed identification
06/30/2005CA2550192A1 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used
06/30/2005CA2550074A1 Novel chelating agents and highly luminescent and stable chelates and their use
06/30/2005CA2550017A1 Protein analysis method
06/30/2005CA2549945A1 Methods and compositions for assaying mutations in nucleic acids and their uses in diagnosis of genetic diseases and cancers
06/30/2005CA2549852A1 Method and nucleic acids for the improved treatment of breast cell proliferative disorders
06/30/2005CA2549849A1 Improved selective ligation and amplification assay
06/30/2005CA2549741A1 Reagent for detecting an analyte
06/30/2005CA2549529A1 Helical synthetic peptides that stimulate cellular cholesterol efflux
06/30/2005CA2549386A1 Methods for synthesis of encoded libraries
06/30/2005CA2549324A1 Gene expression profiles and methods of use
06/30/2005CA2549303A1 Novel sodium channel
06/30/2005CA2549031A1 Method for obtaining an enriched population of sirna-expressing cells
06/30/2005CA2548985A1 Carbon electrode surface for attachment of dna and protein molecules
06/30/2005CA2548769A1 Ztnf 12, a tumor necrosis factor
06/30/2005CA2548577A1 Multiplexed electrochemical detection system and method
06/30/2005CA2548394A1 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
06/30/2005CA2548285A1 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
06/30/2005CA2548099A1 Stabilized susceptibility tests of aerobic pathogens
06/30/2005CA2547635A1 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
06/30/2005CA2547563A1 Corn plant mon88017 and compositions and methods for detection thereof
06/30/2005CA2546811A1 Methods of identifying, selecting and/or characterizing compounds which modulate the activity of a src family kinase
06/30/2005CA2545006A1 Biosensors for detecting macromolecules and other analytes
06/30/2005CA2541769A1 Medium for identification of micro-organisms
06/29/2005EP1548445A2 Novel targets for obesity from fat tissue
06/29/2005EP1548438A1 Interaction detecting method and bioassay device, and bioassay-use substrate
06/29/2005EP1548437A1 Method and apparatus for arranging liquid reaction components on substrate surface for detecting target substance by reaction among plural reaction components on substrate and article utilized in the method
06/29/2005EP1548427A1 Biosensor and method for manufacturing same
06/29/2005EP1548423A1 Image processing method for biochemical test
06/29/2005EP1548132A1 Nucleic acid labeling method by PCR
06/29/2005EP1548131A2 Novel targets for obesity from skeletal muscle
06/29/2005EP1548130A1 Fen endonucleases
06/29/2005EP1548129A1 Method of diagnosing integration dysfunction syndrome using blood
06/29/2005EP1548128A1 Method of recovering dna
06/29/2005EP1548127A1 PRIMER AND PROBE FOR DETECTING i VIBRIO VULNIFICUS /i AND DETECTION METHOD USING THE SAME
06/29/2005EP1548126A1 Solid support for control nucleic acid, and application thereof to nucleic acid detection
06/29/2005EP1548125A1 Method and kit for genotyping the sheep and goat prion protein gene
06/29/2005EP1548124A1 Method and apparatus for washing solid substrate with ultrasonic wave after hybridization reaction
06/29/2005EP1548123A1 Methods of screening agents for activity using teleosts
06/29/2005EP1548118A2 Complementary adenoviral vector systems and cell lines
06/29/2005EP1548115A1 Fructosylamine oxidase
06/29/2005EP1548113A1 A method for obtaining circular mutated and/or chimaeric polynucleotides
06/29/2005EP1548112A1 Method of amplifying nucleic acid, reagent kit for amplifying nucleic acid, method of detecting single nucleotide polymorphism and reagent kit for detecting single nucleotide polymorphism
06/29/2005EP1548111A1 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof
06/29/2005EP1548108A1 Method of screening physiologically active substance
06/29/2005EP1548105A1 Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same
06/29/2005EP1548103A1 Hybridization sensing part, sensor chip, and hybridization method
06/29/2005EP1548102A1 Solid support having electrostatic layer and use thereof
06/29/2005EP1547678A2 Process for high-yield synthesis of nucleic acid arrays
06/29/2005EP1547677A1 Spotting device for manufacturing DNA microarray and spotting method using the same
06/29/2005EP1547607A1 Bacterial cell wall skeleton component preparation
06/29/2005EP1547603A2 Compositions and methods for use in targeting vascular destruction
06/29/2005EP1547462A1 Brassica plant resistant to the fungus Leptosphaeria maculans (blackleg)
06/29/2005EP1546983A2 Controlled aligment of nano-barcodes encoding specific information for scanning probe microscopy (spm) reading
06/29/2005EP1546733A2 Methods and compositions for modification of splicing of pre-mrna
06/29/2005EP1546731A2 Method for treating or preventing metastasis of colorectal cancers
06/29/2005EP1546730A2 Method for treating or preventing metastasis of colorectal cancers
06/29/2005EP1546727A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
06/29/2005EP1546719A2 Isolation and identification of t cells
06/29/2005EP1546718A2 Method for determining the regulation of xenobiotic removal
06/29/2005EP1546717A1 Analyzing nerve cell damage
06/29/2005EP1546713A1 Evaluation method for predicting pharmacokinetics of pm using liver cells of pm of drug metabolizing enzyme cytochrome p450 having a genetic polymorph
06/29/2005EP1546712A2 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases
06/29/2005EP1546710A2 Method and device for monitoring platelet function
06/29/2005EP1546709A2 Cell-based detection and differentiation of disease states
06/29/2005EP1546704A2 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE